Press releases
Press releases
Here we list English translations of the Swedish press releases published by Neola Medical AB (publ). For official press releases, please visit our Swedish website.
Successful results in completed Human Factors Validation Study with Neola® in the USA
Press communication Lund, Sweden, April 18, 2024 This is a translation of the Swedish press release published 2024-04-18 Neola Medical AB (publ) has completed the Human Factors Validation Study with Neola®, the company's medical device for continuous lung...
Notice to the Annual general meeting of Neola Medical AB
️Press communication Lund, Sweden, April 10, 2024 Read the entire press release here: Press release - KALLELSE TILL ÅRSSTÄMMA I NEOLA MEDICAL AB For further information, contact: Hanna Sjöström, CEO Neola Medical, phone: +46 (0)760-10 71 16, e-mail:...
Neola Medical AB publishes Annual report 2023
Press communication Lund, Sweden, April 9, 2024 This is a translation of the Swedish press release published 2024-04-09 Neola Medical AB (publ) announces that the Annual report of 2023 now is available at the company's website, and attached to the press release....
Neola® wins silver medal and 25 000 USD in Stanford Pediatric Device Consortium (PDC) Accelerator Pitch Competition 2024
Press communication Lund, Sweden, March 28, 2024 This is a translation of the Swedish press release published 2024-03-28 Neola Medical's product for lung monitoring of preterm born infants, Neola®, was selected by Stanford as one of the top ten most promising...
Neola Medical’s CEO shares more about the latest news in the spring investor letter
Press communication Lund, Sweden, March 20, 2024 This is a translation of the Swedish press release published 2024-03-20 The initial months of 2024 continue with intensive work and positive progress for Neola Medical in preparation for upcoming studies for market...
Neola Medical initiates Human Factors Validation Study in the USA ahead of FDA application for market approval
Press communication Lund, Sweden, February 29 This is a translation of the Swedish press release published 2024-02-29, 07.00 CET Neola Medical AB (publ) will commence a Human Factors Validation Study in March 2024 with Neola®, the company's medical device for...
Neola Medical Q4 report of 2023 – With a strengthened cash position, another show of strength is delivered through patent protection for future profitability drivers
Press communication Lund, Sweden, February 14 This is a translation of the Swedish press release published 2024-02-14, 08.00 CET Neola Medical AB (publ) today publishes the Q4 report of 2023 (in Swedish). The report is available at the company's website and is...
Neola Medical invites to presentation of the Q4-report 2023
Press communication Lund, Sweden, 5 February 2024 This is a translation of the Swedish press release published 2024-02-05 Neola Medical AB (publ) invites to presentation of the Q4-report of 2023, Wednesday the 14th of February 2024 at 11am CET (11.00). The...
CEO Hanna Sjöström is participating in the J.P. Morgan Healthcare Conference in San Francisco for meetings with investors and industry partners
Press communication Lund, Sweden, January 8 2024 This is a translation of the Swedish press release published 2024-01-08 Neola Medical AB (publ) will be present at the investor conference J.P. Morgan Healthcare Conference in San Francisco in January 2024. CEO Hanna...
Neola Medical’s CEO shares more about the latest news in the winter investor letter 2023
Press communication Lund, Sweden, December 19 2023 This is a translation of the Swedish press release published 2023-12-19 Market preparations for the launch in the U.S. continue with the newly established subsidiary, Neola Medical, Inc., in the U.S, new patent for...
